Companies
- Companies
- Company details
Proteome Sciences
Proteome Sciences is a global leader in applied proteomics applying high sensitivity proprietary technologies to detect differentially expressed proteins in diseases.The company in detail
Summary
Proteome Sciences, is involved in applied proteomics, uses high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases). The biomarkers discovered in body fluids or tissues are validated, developed and commercialised as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. Since its inception in 1994, Proteome Sciences has discovered a large number of novel protein biomarkers in key human diseases and has established a broad portfolio of products/licensing from Intellectual Property (IP) related to differential protein expression.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2012 - 23 pages - $250
Feb 2011 - 34 pages - $125
May 2011 - 37 pages - $125
Dec 2010 - 21 pages - $99
Feb 2011 - 25 pages - $99
Nov 2010 - 27 pages - $99
Jul 2010 - 26 pages - $99
Apr 2010 - 24 pages - $99
Jun 2011 - 30 pages - $125
Nov 2010 - 42 pages - $600
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us